Wells Fargo’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5,544	Closed	-$838K	–	8061
2022 Q3	$838K	Sell	5,544 -2,805	-34%	-$416K	﹤0.01%	3346
2022 Q2	$1.22M	Sell	8,349 -71,523	-90%	-$9.14M	﹤0.01%	3165
2022 Q1	$9.47M	Sell	79,872 -21,636	-21%	-$2.7M	﹤0.01%	1880
2021 Q4	$14M	Sell	101,508 -1,675,910	-94%	-$213M	﹤0.01%	1603
2021 Q3	$247M	Buy	1,777,418 +346,231	+24%	+$43.2M	0.06%	342
2021 Q2	$139M	Buy	1,431,187 +295,977	+26%	+$24M	0.03%	526
2021 Q1	$77.6M	Buy	1,135,210 +137,173	+14%	+$11.1M	0.02%	811
2020 Q4	$85.5M	Sell	998,037 -67,086	-6%	-$5.68M	0.02%	712
2020 Q3	$69.2M	Buy	1,065,123 +179,306	+20%	+$11.8M	0.02%	713
2020 Q2	$64.8M	Buy	885,817 +546,031	+161%	+$29.1M	0.02%	732
2020 Q1	$11.6M	Buy	339,786 +306,285	+914%	+$14M	﹤0.01%	1575
2019 Q4	$1.82M	Sell	33,501 -5,669	-14%	-$281K	﹤0.01%	3414
2019 Q3	$1.63M	Buy	39,170 +5,995	+18%	+$253K	﹤0.01%	3494
2019 Q2	$1.45M	Sell	33,175 -2,990	-8%	-$169K	﹤0.01%	3605
2019 Q1	$1.86M	Sell	36,165 -3,809	-10%	-$165K	﹤0.01%	3416
2018 Q4	$1.48M	Buy	39,974 +1,439	+4%	+$51.9K	﹤0.01%	3531
2018 Q3	$1.45M	Buy	38,535 +807	+2%	+$29.7K	﹤0.01%	3681
2018 Q2	$1.49M	Sell	37,728 -3,456	-8%	-$110K	﹤0.01%	3689
2018 Q1	$1.06M	Buy	41,184 +11,373	+38%	+$340K	﹤0.01%	3867
2017 Q4	$805K	Sell	29,811 -5,996	-17%	-$165K	﹤0.01%	4072
2017 Q3	$1.34M	Buy	35,807 +9,594	+37%	+$291K	﹤0.01%	3629
2017 Q2	$655K	Buy	+26,213	New	+$604K	﹤0.01%	4044

Other funds holding BHVN